CD47 and urinary bladder carcinoma: Subsequently, this same group showed that blocking CD47 with a monoclonal antibody enabled macrophages to phagocytose bladder cancer cells in vivo, inhibit tumor growth, and prevent metastases in xenotransplantation models [1,11].